adsa January 2009

OYC Americas, Inc. is pleased to announce the launch of recombinant human soluble RANKL (sRANKL) to support osteoporosis and bone metabolism research initiatives. Receptor activator of NF-kB ligand (RANKL), also designated TRANCE, OPGL and ODF, is a member of the … Continue reading →

Andover, MA. OYC International officially launched its new corporate name and brand image, OYC Americas. This important change is a reflection of our new role and responsibility for the OYC group to expand business and market share in North and … Continue reading →